A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy
- 1 July 2006
- journal article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 16 (4), 1614-1619
- https://doi.org/10.1111/j.1525-1438.2006.00635.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the CervixJournal of Clinical Oncology, 2000
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group StudyJournal of Clinical Oncology, 1999
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Predicting Glomerular Function from Adjusted Serum CreatinineNephron, 1992
- Cyclophosphamide, adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinomaGynecologic Oncology, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976